$0.0303
0.001053.59%
At close: -
$0.0280
-0.00230-7.59%
After Hours: Jan 27, 9:28 AM EDT
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
There have been no specific sales or earnings guidance reported for Oncotelic Therapeutics in recent months.
Browse guidance and forecast on all stocks.